Creating a market access strategy for Zulresso® /

Sage Therapeutics is a neuroscience-focused biopharmaceutical company founded in Cambridge, Massachusetts, in 2010. Their primary focus is on introducing innovative therapies and solutions for brain disorders. Zulresso®, Sage's only marketed product as of 2022, received its FDA approval under p...

Full description

Bibliographic Details
Main Authors: Dasgupta, Swikriti (Author), Sharma, Taijasi (Author), Munshaw, Supriya (Author)
Format: eBook
Language:English
Published: London : SAGE Publications: SAGE Business Cases Originals, 2023.
Series:Sage business cases.
Subjects:
Online Access:Connect to the full text of this electronic book

MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000Mi 4500
001 in00005498721
006 m o d
007 cr un|||||||||
008 230606s2023 enk fo 000 0 eng d
005 20240923171932.3
035 |a (OCoLC)on1382591819 
040 |a SGPBL  |b eng  |e rda  |e pn  |c SGPBL  |d OCLCF  |d OCLCO 
020 |a 9781071915882  |q (SAGE Business Cases) 
020 |a 1071915886 
035 |a (OCoLC)1382591819 
050 4 |a HF5415.153  |b .D37 2023 
082 0 4 |a 658.575 
049 |a TXAM 
100 1 |a Dasgupta, Swikriti,  |e author. 
245 1 0 |a Creating a market access strategy for Zulresso® /  |c Swikriti Dasgupta, Taijasi Sharma, and Supriya Munshaw. 
264 1 |a London :  |b SAGE Publications: SAGE Business Cases Originals,  |c 2023. 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Sage business cases 
520 8 |a Sage Therapeutics is a neuroscience-focused biopharmaceutical company founded in Cambridge, Massachusetts, in 2010. Their primary focus is on introducing innovative therapies and solutions for brain disorders. Zulresso®, Sage's only marketed product as of 2022, received its FDA approval under priority review in March 2019. Zulresso® is indicated for treating postpartum depression (PPD) in adults. This was the first medication indicated solely for this condition. Sage had to consider various commercial challenges in launching this product. This case will introduce students to some of these challenges through the concept of a market access strategy for a pharmaceutical product. 
588 |a Description based on XML content. 
650 0 |a New products  |v Case studies. 
650 0 |a Business planning  |v Case studies. 
650 7 |a Business planning  |2 fast 
650 7 |a New products  |2 fast 
655 7 |a Electronic books.  |2 local 
655 7 |a Case studies  |2 fast 
700 1 |a Sharma, Taijasi,  |e author. 
700 1 |a Munshaw, Supriya,  |e author. 
830 0 |a Sage business cases. 
856 4 0 |u http://proxy.library.tamu.edu/login?url=https://sk.sagepub.com/cases/creating-a-market-access-strategy-for-zulresso  |z Connect to the full text of this electronic book  |t 0 
955 |a SAGE eBooks 
955 |a SAGE Business Cases 2023 Annual Collection 
994 |a 92  |b TXA 
999 f f |s 0a018316-6ea9-4cd3-b2fc-d5ffb3c0e4de  |i ce04fc7c-68e3-40a8-94e5-adfad93cb807  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |d Available Online  |t 0  |e HF5415.153 .D37 2023  |h Library of Congress classification 
998 f f |a HF5415.153 .D37 2023  |t 0  |l Available Online